Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
05/2001
05/09/2001EP1097707A1 Treatment of female sexual dysfunction
05/09/2001EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments
05/09/2001EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides
05/09/2001EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/09/2001EP0633776B1 Compounds useful for treating allergic and inflammatory diseases
05/09/2001CN1294578A Novel naphthyl-substituted and anilide-substituted sulfonanides
05/09/2001CN1294577A 钾通道抑制剂 Potassium channel inhibitors
05/09/2001CN1065521C Fluoroalkylethoxylate compsns. having enhanced water solubility
05/08/2001US6229025 Process for alkylating hindered sulfonamides
05/08/2001US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/08/2001US6228808 Carbamoylphenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2167040C New alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them
05/03/2001WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
05/03/2001WO2001030731A1 Method for preparing a non-crystallizable polyol syrup
05/03/2001WO2000066546A3 Monofluoroalkyl derivatives
05/02/2001EP1095930A1 Novel compounds
05/02/2001EP1095925A1 Process for the preparation of a non crystallizing polyol syrop
05/02/2001EP1095071A1 Aromatic polymers with pendant fluorinated ionic groups
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094812A1 Angiogenesis inhibitors
05/02/2001CN1293668A Process for synthesis of HTV protease inhibitors
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1293665A New compounds and their use as positive AMPA receptor modulators
05/02/2001CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
05/02/2001CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them
05/01/2001US6225480 Sulphonyl compounds for use as linkers in solid phase and combinatorial synthesis
05/01/2001US6225346 Tyrphostin like compounds
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6225311 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
05/01/2001US6225302 Amidino protease inhibitors
04/2001
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001WO2001028537A2 Bissulfonamide derivatives as enzyme inhibitors
04/26/2001WO2000055125A3 N-cyanomethyl amides as protease inhibitors
04/26/2001US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation
04/26/2001CA2387593A1 Enzyme inhibitors
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001CN1064957C N-sulphonyl and N-sulphinyl amino acid amides as microbiocides
04/25/2001CN1064955C Fluorine-containing benzoylguanidines
04/24/2001US6222072 Racting imine with hydride reagent in presence of optically active metal compound, wherein hydride reagent is a metal hydride, reagent that undergoes metal exchange, metal trialkoxy hydride complex or metal(tricarboxylic acid)hydride
04/24/2001US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde
04/24/2001US6221914 Sulfonamide bridging compounds that inhibit tryptase activity
04/24/2001US6221898 Anticoagulants
04/24/2001US6221866 Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them
04/22/2001WO2002102250A1 $g(in vivo) imaging
04/22/2001CA2422767A1 In vivo imaging
04/19/2001WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors
04/19/2001WO2001027084A1 Beta disubstituted metalloprotease inhibitors
04/19/2001CA2386485A1 Beta disubstituted metalloprotease inhibitors
04/18/2001EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
04/18/2001EP0904265B1 Preparation of bis(fluoroalkylenesulfonyl)imides and (fluoroalkylsulfonyl) (fluorosulfonyl)imides
04/18/2001CN1292005A Substantially fluorinated ionomers
04/18/2001CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide
04/18/2001CN1064676C Ortho-substituted benzoyl guanidine, its preparation, use and medicines containing it
04/17/2001US6218565 Method for producing N-(3-amino-4-fluoro-phenyl)-sulphonamides, N-(3-amino-4-fluoro-phenyl)-carboxylic acid amides and N-(3-amino-4-fluorophenyl) carbamates
04/17/2001US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices
04/12/2001WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
04/12/2001WO2001025172A1 A method for preparing and screening one or more compounds
04/12/2001WO2001025171A1 Chemical constructs
04/12/2001WO2001024786A1 Preventive or therapeutic drugs for diabetes
04/12/2001CA2385715A1 A method for preparing and screening one or more compounds
04/12/2001CA2372715A1 Preventive or therapeutic drugs for diabetes
04/11/2001EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/11/2001EP1089966A1 Novel compounds useful in pain management
04/11/2001CN1291184A Cycloalkene derivatives, process for producing the same and use
04/11/2001CN1290695A 6-amino-2-naphthalenesulfonyl methyl amine and its preparing method and use
04/10/2001US6214882 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
04/10/2001US6214881 Chemokine sensitive disease
04/10/2001US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia
04/10/2001US6214872 Antiarthritic and anticarcinogenic agents
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/10/2001US6214800 Angiogenesis inhibitors
04/05/2001WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives
04/05/2001WO2001023352A2 Preparation of sulfonyl imine compounds
04/05/2001WO2001023349A1 Acylsulfonamide derivatives
04/05/2001WO2001023347A1 Novel aromatic compounds
04/05/2001DE19953051A1 Fluorinated sulfonamide compounds, useful as non-flammable solvents in electrolytes for electrochemical cells, e.g. lithium batteries for mobile telephones
04/05/2001DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
04/05/2001CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives
04/05/2001CA2378028A1 Preparation of sulfonyl imine compounds
04/04/2001EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives
04/04/2001EP1088814A1 Fluorinated sulfonamides as highly flame-resistant solvents for use in electrochemical cells
04/04/2001EP1087953A1 Nitrate salts of antihypertensive medicines
04/04/2001CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases
04/04/2001CN1289765A Fluorinated sulfamide for low combustible solvent in electrochemical batteries
04/04/2001CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them
04/03/2001US6211241 Aryl sulfonamides and sulfamide derivatives and uses thereof
04/03/2001US6211234 Substituted phenyl compounds
04/03/2001US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction
03/2001
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001002350A3 Novel amino sulfonamides and amido sulfonamides as antiviral agents
03/29/2001WO2000077057A3 Fluorinated ionic polymers